Ignite Creation Date:
2024-05-06 @ 10:15 AM
Last Modification Date:
2024-10-26 @ 12:27 PM
Study NCT ID:
NCT03206931
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2021-09-16
First Post:
2017-06-29
Brief Title:
Expanded Access to Provide Selitrectinib for the Treatment of Cancers With a NTRK Gene Fusion
Sponsor:
Bayer
Organization:
Bayer